Arch Therapeutics Inc (ARTHQ)

Arch Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing an approach to stop bleeding (hemostasis), control leaking (sealant), and manage wounds during surgery, trauma, and interventional care. It is developing products based on a self-assembling barrier technology platform for patients. The company markets medical devices, such as AC5 Advanced Wound System and AC5 Topical Hemostat in the United States and Europe. Its development stage product candidates inc...